YOUR BUSINESS AUTHORITY
Springfield, MO
AbbVie signed on to buy rival drugmaker Allergan for $63 billion.
The bid values Allergan's shares at a 45% premium.
The acquisition would combine AbbVie, the maker of arthritis drug Humira, and Allergan, which is known for its wrinkle treatment Botox, among other products.
Read more from Bloomberg.
Jordan Valley Senior Care offers all-inclusive care, activities space.
Harry Cooper Supply acquires longtime Queen City biz
Ice cream novelty maker to close Brentwood operation, lay off 107
UMB Bank parent pens acquisition
Bass Pro sets opening date for New Jersey store
New leader picked to oversee Bartlett & West Construction